Expansion, reexpansion, and recall-like expansion of Vγ2Vδ2 T cells in smallpox vaccination and monkeypox virus infection

Journal of Virology

Volumn 83, Issue 22, 2009, Pages 11959-11965

  Shao, Lingyun ^a,c   Huang, Dan ^a   Wei, Huiyong ^a   Wang, Richard C ^a   Chen, Crystal Y ^a   Shen, Ling ^b   Zhang, Wenhong ^c   Jin, Jialin ^a   Chen, Zheng W ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; GAMMA INTERFERON; MESSENGER RNA; PHOSPHOANTIGEN; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMORAL IMMUNITY; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATION; INTERFERON PRODUCTION; LUNG PARENCHYMA; LYMPHOCYTE FUNCTION; MACACA; MONKEYPOX; MONKEYPOX VIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VACCINIA VIRUS; VGAMMA2VDELTA2 T LYMPHOCYTE;

ANIMALS; ANTIVIRAL AGENTS; CYTOSINE; FEMALE; INTERFERON-GAMMA; LUNG; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MONKEYPOX; MONKEYPOX VIRUS; PHOSPHONIC ACIDS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SMALLPOX VACCINE; T-LYMPHOCYTE SUBSETS; VACCINIA VIRUS;

MACACA; MONKEYPOX VIRUS; MOROCCAN PEPPER VIRUS; VARIOLA VIRUS;

EID: 70350325589     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00689-09     Document Type: Article

References (26)

1. + T cells capable of antigen-specific expansion and effector functions. J. Infect. Dis. 192:1362-1371.
2. Agrati, C., C. Castilletti, R. De Santis, E. Cimini, L. Bordi, M. Malkovsky, F. Poccia, and M. R. Capobianchi. 2006. Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T cells. J. Infect. Dis. 193:1606-1607. (Author's reply, 1607-1608.)
3. Ali, Z., L. Shao, L. Halliday, A. Reichenberg, M. Hintz, H. Jomaa, and Z. W. Chen. 2007. Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphatedriven antimicrobial and cytotoxic responses of pulmonary and systemic Vγ2Vδ2 T cells in macaques. J. Immunol. 179:8287-8296.
4. Born, W. K., C. L. Reardon, and R. L. O'Brien. 2006. The function of γδ T cells in innate immunity. Curr. Opin. Immunol. 18:31-38.
5. Casetti, R., G. Perretta, A. Taglioni, M. Mattei, V. Colizzi, F. Dieli, G. D'Offizi, M. Malkovsky, and F. Poccia. 2005. Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2. J. Immunol. 175:1593-1598. (Pubitemid 41023061)
6. Chen, Z. W., and N. L. Letvin. 2003. Adaptive immune response of Vγ2Vδ2 T cells: a new paradigm. Trends Immunol. 24:213-219.
7. Dieli, F., F. Poccia, M. Lipp, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno. 2003. Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 198:391-397.
8. Eberl, M., M. Hintz, A. Reichenberg, A. K. Kollas, J. Wiesner, and H. Jomaa. 2003. Microbial isoprenoid biosynthesis and human γδ T cell activation. FEBS Lett. 544:4-10. (Pubitemid 36628027)
9. Edghill-Smith, Y., H. Golding, J. Manischewitz, L. R. King, D. Scott, M. Bray, A. Nalca, J. W. Hooper, C. A. Whitehouse, J. E. Schmitz, K. A. Reimann, and G. Franchini. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11:740-747.
10. Fournie, J. J., and M. Bonneville. 1996. Stimulation of gamma delta T cells by phosphoantigens. Res. Immunol. 147:338-347.
11. + T regulatory cells. Blood 113:837-845.
12. Hooper, J. W., E. Thompson, C. Wilhelmsen, M. Zimmerman, M. A. Ichou, S. E. Steffen, C. S. Schmaljohn, A. L. Schmaljohn, and P. B. Jahrling. 2004. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78:4433-4443.
13. Huang, D., C. Y. Chen, Z. Ali, L. Shao, L. Shen, H. A. Lockman, R. E. Barnewall, C. Sabourin, J. Eestep, A. Reichenberg, M. Hintz, H. Jomaa, R. Wang, and Z. W. Chen. 2009. Antigen-specific Vγ2Vδ2 T effector cells confer homeostatic protection against pneumonic plaque lesions. Proc. Natl. Acad. Sci. USA 106:7553-7558.
14. Huang, D., Y. Shen, L. Qiu, C. Y. Chen, L. Shen, J. Estep, R. Hunt, D. Vasconcelos, G. Du, P. Aye, A. A. Lackner, M. H. Larsen, W. R. Jacobs, Jr., B. F. Haynes, N. L. Letvin, and Z. W. Chen. 2008. Immune distribution and localization of phosphoantigen-specific Vγ2Vδ2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect. Immun. 76:426-436.
15. Li, H., C. O. Deetz, J. C. Zapata, C. Cairo, A. M. Hebbeler, N. Propp, M. S. Salvato, Y. Shao, and C. D. Pauza. 2007. Vaccinia virus inhibits T cell receptor-dependent responses by human γδ T cells. J. Infect. Dis. 195:37-45.
16. Martino, A., R. Casetti, A. Sacchi, and F. Poccia. 2007. Central memory Vγ9Vδ2 T lymphocytes primed and expanded by bacillus Calmette-Guérininfected dendritic cells kill mycobacterial-infected monocytes. J. Immunol. 179:3057-3064.
17. Pitard, V., D. Roumanes, X. Lafarge, L. Couzi, I. Garrigue, M. E. Lafon, P. Merville, J. F. Moreau, and J. Dechanet-Merville. 2008. Long-term expansion of effector/memory Vδ2-γδ T cells is a specific blood signature of CMV infection. Blood 112:1317-1324.
18. Poccia, F., C. Agrati, C. Castilletti, L. Bordi, C. Gioia, D. Horejsh, G. Ippolito, P. K. Chan, D. S. Hui, J. J. Sung, M. R. Capobianchi, and M. Malkovsky. 2006. Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V γ 9V δ 2 T cells. J. Infect. Dis. 193:1244-1249.
19. + T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans. AIDS 22:2241-2250.
20. Sharp, L. L., J. M. Jameson, D. A. Witherden, H. K. Komori, and W. L. Havran. 2005. Dendritic epidermal T-cell activation. Crit. Rev. Immunol. 25:1-18.
21. + T cells during mycobacterial infections. Science 295:2255-2258.
22. Sicard, H., S. Ingoure, B. Luciani, C. Serraz, J. J. Fournie, M. Bonneville, J. Tiollier, and F. Romagne. 2005. In vivo immunomanipulation of V γ 9V δ 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 175:5471-5480.
23. Stittelaar, K. J., G. van Amerongen, I. Kondova, T. Kuiken, R. F. van Lavieren, F. H. Pistoor, H. G. Niesters, G. van Doornum, B. A. van der Zeijst, L. Mateo, P. J. Chaplin, and A. D. Osterhaus. 2005. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J. Virol. 79:7845-7851.
24. Wei, H., D. Huang, J. Fortman, R. Wang, L. Shao, and Z. W. Chen. 2008. coadministration of Cidofovir and smallpox vaccine reduced vaccination side effect but interfered with vaccine-elicited immune responses and immunity to monkeypox. J. Virol. 83:1115-1125.
25. Wei, H., D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen. 2008. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl- but-2-enyl pyrophosphate to Vγ2Vδ2 2 TCR. J. Immunol. 181:4798-4806.
26. Worku, S., G. J. Gorse, R. B. Belshe, and D. F. Hoft. 2001. Canarypox vaccines induce antigen-specific human γδ T cells capable of interferongamma production. J. Infect. Dis. 184:525-532.